Edwards Lifesciences

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EW and other ETFs, options, and stocks.

About EW

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care.

CEO

Bernard J. Zovighian

CEOBernard J. Zovighian

Employees

15,800

Employees15,800

Headquarters

Irvine, California

HeadquartersIrvine, California

Founded

1958

Founded1958

Employees

15,800

Employees15,800

EW Key Statistics

Market cap

43.07B

Market cap43.07B

Price-Earnings ratio

50.08

Price-Earnings ratio50.08

Dividend yield

—

Dividend yield—

Average volume

4.02M

Average volume4.02M

High today

—

High today—

Low today

—

Low today—

Open price

$72.59

Open price$72.59

Volume

0.00

Volume0.00

52 Week high

$83.00

52 Week high$83.00

52 Week low

$64.89

52 Week low$64.89

EW News

Simply Wall St 7d

How Edwards Lifesciences' Next-Gen Heart Valve Launch in Thailand Could Shape Its Growth Outlook

Edwards Lifesciences recently launched its next-generation transcatheter heart valve in Thailand, featuring calcification-resistant tissue and improved sealing...

Seeking Alpha 7d

Edwards Lifesciences slips as Oppenheimer downgrades on upcoming data

Shares of Edwards Lifesciences (NYSE:EW) fell on Wednesday after Oppenheimer downgraded the cardiac device maker to Perform from Outperform, citing concerns ove...

Analyst ratings

53%

of 36 ratings

Buy

52.8%

Hold

44.4%

Sell

2.8%

People also own

Based on the portfolios of people who own EW. This list is generated using Robinhood data, and it’s not a recommendation.